×
Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF
$ 40.00
Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF quantity
$ 40.00
×
Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease PDF
$ 40.00
Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease PDF quantity
$ 40.00
×
Aggressive Patient Behaviors Related to Medical Care: A Cross-Sectional Self-Report Survey PDF
$ 40.00
Aggressive Patient Behaviors Related to Medical Care: A Cross-Sectional Self-Report Survey PDF quantity
$ 40.00
×
Incidence of Cardiovascular Outcomes and Diabetes Mellitus Among Users of Second-Generation Antipsychotics PDF
$ 40.00
Incidence of Cardiovascular Outcomes and Diabetes Mellitus Among Users of Second-Generation Antipsychotics PDF quantity
$ 40.00
×
A Possible Role for Uncaria tomentosa (cat’s claw) in a Case of Serotonin Syndrome PDF
$ 40.00
A Possible Role for Uncaria tomentosa (cat’s claw) in a Case of Serotonin Syndrome PDF quantity
$ 40.00
×
Psychosis After SARS-CoV-2 in a Patient With Stable Schizophrenia and Allograft Kidney Transplant PDF
$ 40.00
Psychosis After SARS-CoV-2 in a Patient With Stable Schizophrenia and Allograft Kidney Transplant PDF quantity
$ 40.00
×
Mild COVID-19 Disease Course With Protracted Delirium in a Cognitively Impaired Patient Over the Age of 85 Years PDF
$ 40.00
Mild COVID-19 Disease Course With Protracted Delirium in a Cognitively Impaired Patient Over the Age of 85 Years PDF quantity
$ 40.00
×
Trends in Office-Based Treatment of Adults With Stimulants in the United States PDF
$ 40.00
Trends in Office-Based Treatment of Adults With Stimulants in the United States PDF quantity
$ 40.00
×
Risks of Suicide and Poisoning Among Elderly Patients Prescribed Selective Serotonin Reuptake Inhibitors: A Retrospective Cohort Study PDF
$ 40.00
Risks of Suicide and Poisoning Among Elderly Patients Prescribed Selective Serotonin Reuptake Inhibitors: A Retrospective Cohort Study PDF quantity
$ 40.00
×
First-Year Medicare Part D Prescription Drug Benefits: Medication Access and Continuity Among Dual Eligible Psychiatric Patients PDF
$ 40.00
First-Year Medicare Part D Prescription Drug Benefits: Medication Access and Continuity Among Dual Eligible Psychiatric Patients PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart